Paraoxonase

A 360 degree view of Serum Paraoxonase-1 (1v04)
paraoxonase 1
Identifiers
SymbolPON1
Alt. symbolsPON
NCBI gene5444
HGNC9204
OMIM168820
RefSeqNM_000446
UniProtP27169
Other data
EC number3.1.8.1
LocusChr. 7 q21.3
Search for
StructuresSwiss-model
DomainsInterPro
paraoxonase 2
Identifiers
SymbolPON2
NCBI gene5445
HGNC9205
OMIM602447
RefSeqNM_000305
UniProtQ15165
Other data
EC number3.1.8.1
LocusChr. 7 q21.3
Search for
StructuresSwiss-model
DomainsInterPro
paraoxonase 3
Identifiers
SymbolPON3
NCBI gene5446
HGNC9206
OMIM602720
RefSeqNM_000940
UniProtQ15166
Other data
EC number3.1.8.1
LocusChr. 7 q21.3
Search for
StructuresSwiss-model
DomainsInterPro

Paraoxonases are a family of mammalian enzymes with aryldialkylphosphatase activity. There are three paraoxonase isozymes, which were originally discovered for their involvement in the hydrolysis of organophosphates.[1]

Research has indicated the enzymatic activity of paraoxonases is more diversified than its activity as an organophosphatase. Esterase and lactonase activity has also been observed from these enzymes and though the physiologically relevant substrates for these enzymes are unknown, it is likely that lactones are the main substrate (although there is a relatively high level of variation in substrate specificity among these enzymes). Most of the studies on the paraoxonase family have specifically looked at the paraoxonase 1 type, leaving much to be learned about the remaining two.[2]

The study of this enzyme family has many potential consequences in preventative medicine and toxicology as well as in certain societal contexts. The genes that encode for these enzymes have a number of different polymorphisms, which created additional interest in the study of this enzyme group and its potential ethnic variations.[3] Additional research on the inhibition and selective inhibition, specifically of PON1, has been done to shed some light on the connections between decreases in enzymatic activity of individuals with cardiovascular diseases.[4] Evidence also suggests that this family of enzymes has some role in our innate immune system.[5]

  1. ^ Cite error: The named reference :0 was invoked but never defined (see the help page).
  2. ^ Litvinov, Dmitry, Halleh Mahini, and Mahdi Garelnabi. “Antioxidant and Anti-Inflammatory Role of Paraoxonase 1: Implication in Arteriosclerosis Diseases.” North American Journal of Medical Sciences 4.11 (2012): 523–532. PMC. Web. 1 Mar. 2016.
  3. ^ Costa, Lucio G., and Clement E. Furlong. Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects. Boston: Kluwer Academic, 2002. Print.
  4. ^ S.D. Nguyen, D.E. Sok. “Oxidative inactivation of Paraoxonase 1 an antioxidant protein and its effect on antioxidant action.” Free Radic Res, 37 (2003), pp. 77–83
  5. ^ Egon A. Ozer, Alejandro Pezzulo, Diana M. Shih, Carlene Chun, Clement Furlong, Aldons J. Lusis, Everett P. Greenberg, Joseph Zabner. Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing FEMS Microbiology Letters Dec 2005, 253 (1) 29-32; DOI: 10.1016/j.femsle.2005.09.023